4,6-Diaminopyrimidine - CAS 2434-56-2
Catalog: |
BB018426 |
Product Name: |
4,6-Diaminopyrimidine |
CAS: |
2434-56-2 |
Synonyms: |
pyrimidine-4,6-diamine; pyrimidine-4,6-diamine |
IUPAC Name: | pyrimidine-4,6-diamine |
Description: | 4,6-Diaminopyrimidine (CAS# 2434-56-2) is a compound used for the preparations of pharmaceutical goods. It was shown that organotin polyamines derived from reaction with 4,6-diaminopyrimidines displayed good inhibition of two pancreatic cancer cell lines. |
Molecular Weight: | 110.12 |
Molecular Formula: | C4H6N4 |
Canonical SMILES: | C1=C(N=CN=C1N)N |
InChI: | InChI=1S/C4H6N4/c5-3-1-4(6)8-2-7-3/h1-2H,(H4,5,6,7,8) |
InChI Key: | MISVBCMQSJUHMH-UHFFFAOYSA-N |
Boiling Point: | 364 °C at 760 mmHg |
Density: | 1.368 g/cm3 |
LogP: | 0.80340 |
GHS Hazard Statement: | H302 (50%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CN-112851587-A | Alkyne heterocyclic compound for treating cancer and preparation method and application thereof | 20210121 |
CN-111793035-A | N4- (3-methoxyphenyl) -pyrimidinediamine targeted DDR1 inhibitor and preparation and application thereof | 20200622 |
CN-111777592-B | N4- (2, 5-dimethoxyphenyl) -pyrimidinediamine targeted DDR1 inhibitor and preparation and application thereof | 20200622 |
CN-111793035-B | N4- (3-methoxyphenyl) -pyrimidinediamine targeted DDR1 inhibitor and preparation and application thereof | 20200622 |
WO-2021198956-A1 | Compounds active towards nuclear receptors | 20200331 |
PMID | Publication Date | Title | Journal |
22223377 | 20120101 | Synthesis, dihydrofolate reductase inhibition, anti-proliferative testing, and saturation transfer difference ¹H-NMR study of some new 2-substituted-4,6-diaminopyrimidine derivatives | Chemical & pharmaceutical bulletin |
17398090 | 20070601 | Dual M3 antagonists-PDE4 inhibitors. Part 2: Synthesis and SAR of 3-substituted azetidinyl derivatives | Bioorganic & medicinal chemistry letters |
16439121 | 20060401 | First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives | Bioorganic & medicinal chemistry letters |
Complexity: | 66.4 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 110.059246208 |
Formal Charge: | 0 |
Heavy Atom Count: | 8 |
Hydrogen Bond Acceptor Count: | 4 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 110.059246208 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 77.8 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | -0.5 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Amines and Anilines
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS